• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鸢尾素在肾脏疾病中的作用。

The role of irisin in kidney diseases.

机构信息

Department of Nephrology, The 2nd Xiangya Hospital, Central South University, Changsha, Hunan, China; Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Clin Chim Acta. 2024 Feb 1;554:117756. doi: 10.1016/j.cca.2023.117756. Epub 2024 Jan 12.

DOI:10.1016/j.cca.2023.117756
PMID:38218331
Abstract

Irisin is a hormone that is produced mainly by skeletal muscles in response to exercise. It has been found to have a close correlation with obesity and diabetes mellitus for its energy expenditure and metabolic properties. Recent research has revealed that irisin also possesses anti-inflammatory, anti-oxidative and anti-apoptotic properties, which make it associated with major chronic diseases, such as chronic kidney disease (CKD), liver diseases, osteoporosis, atherosclerosis and Alzheimer s disease. The identification of irisin has not only opened up new possibilities for monitoring metabolic and non-metabolic diseases but also presents a promising therapeutic target due to its multiple biological functions. Studies have shown that circulating irisin levels are lower in CKD patients than in non-CKD patients and decrease with increasing CKD stage. Furthermore, irisin also plays a role in many CKD-related complications like protein energy wasting (PEW), cardiovascular disease (CVD) and chronic kidney disease-mineral and bone disorder (CKD-MBD). In this review, we present the current knowledge on the role of irisin in kidney diseases and their complications.

摘要

鸢尾素是一种激素,主要由骨骼肌在运动时产生。由于其能量消耗和代谢特性,它与肥胖症和糖尿病密切相关。最近的研究表明,鸢尾素还具有抗炎、抗氧化和抗凋亡特性,使其与慢性肾脏病 (CKD)、肝脏疾病、骨质疏松症、动脉粥样硬化和阿尔茨海默病等主要慢性疾病相关。鸢尾素的发现不仅为监测代谢和非代谢疾病开辟了新的可能性,而且由于其多种生物学功能,也为治疗提供了有前途的靶点。研究表明,CKD 患者的循环鸢尾素水平低于非 CKD 患者,并且随着 CKD 阶段的增加而降低。此外,鸢尾素在许多 CKD 相关并发症中也发挥作用,如蛋白能量消耗 (PEW)、心血管疾病 (CVD) 和慢性肾脏病-矿物质和骨异常 (CKD-MBD)。在这篇综述中,我们介绍了鸢尾素在肾脏疾病及其并发症中的作用的最新知识。

相似文献

1
The role of irisin in kidney diseases.鸢尾素在肾脏疾病中的作用。
Clin Chim Acta. 2024 Feb 1;554:117756. doi: 10.1016/j.cca.2023.117756. Epub 2024 Jan 12.
2
Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.骨质疏松症与慢性肾脏病-矿物质和骨异常(CKD-MBD):回归基础
Am J Kidney Dis. 2021 Oct;78(4):582-589. doi: 10.1053/j.ajkd.2020.12.024. Epub 2021 Mar 25.
3
Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD.慢性肾脏病(CKD)-矿物质和骨异常(MBD)在 CKD 患者心血管疾病发病机制中的作用。
J Atheroscler Thromb. 2023 Aug 1;30(8):835-850. doi: 10.5551/jat.RV22006. Epub 2023 May 30.
4
Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis.接受透析治疗的患者中慢性肾脏病-矿物质和骨异常(CKD-MBD)与营养不良-炎症复合征(MICS)之间新出现的相互作用。
Clin Exp Nephrol. 2022 Jul;26(7):613-629. doi: 10.1007/s10157-022-02216-x. Epub 2022 Mar 30.
5
Circulating irisin level in chronic kidney disease patients: a systematic review and meta-analysis.慢性肾脏病患者循环鸢尾素水平:一项系统评价和荟萃分析。
Int Urol Nephrol. 2022 Jun;54(6):1295-1302. doi: 10.1007/s11255-021-03000-8. Epub 2021 Sep 28.
6
Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.激活素 A 信号的系统激活导致慢性肾脏病-矿物质骨代谢紊乱。
Int J Mol Sci. 2018 Aug 23;19(9):2490. doi: 10.3390/ijms19092490.
7
Mineral metabolism and cardiovascular disease in CKD.慢性肾脏病中的矿物质代谢与心血管疾病
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):53-63. doi: 10.1007/s10157-016-1363-8. Epub 2017 Jan 6.
8
Serum Irisin May Predict Cardiovascular Events in Elderly Patients With Chronic Kidney Disease Stage 3-5.血清鸢尾素可能预测3-5期老年慢性肾脏病患者的心血管事件。
J Ren Nutr. 2022 May;32(3):282-291. doi: 10.1053/j.jrn.2021.05.007. Epub 2021 Oct 20.
9
The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.慢性肾脏病-矿物质与骨异常(CKD-MBD):病理生理学进展
Bone. 2017 Jul;100:80-86. doi: 10.1016/j.bone.2017.01.023. Epub 2017 Jan 22.
10
Adropin and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease.动脉高血压、糖尿病和慢性肾病中的分泌素和鸢尾素。
Adv Clin Exp Med. 2019 Nov;28(11):1571-1575. doi: 10.17219/acem/104551.

引用本文的文献

1
Association of Serum Irisin With Severity and Prognosis in Patients With Coronavirus Disease 2019: A Prospective Cohort Study.2019冠状病毒病患者血清鸢尾素与疾病严重程度和预后的关联:一项前瞻性队列研究
Int J Gen Med. 2025 Feb 10;18:659-670. doi: 10.2147/IJGM.S500848. eCollection 2025.
2
Serum Irisin Levels Are Positively Correlated with Physical Activity Capacity in Hemodialysis Patients.血清鸢尾素水平与血液透析患者的身体活动能力呈正相关。
Kidney Blood Press Res. 2025;50(1):105-114. doi: 10.1159/000543214. Epub 2025 Jan 3.
3
Physical activity and renal outcome in diabetic and non-diabetic patients with chronic kidney disease stage G3b to G5.
慢性肾脏病 G3b 至 G5 期的糖尿病和非糖尿病患者的体力活动与肾脏结局。
Sci Rep. 2024 Nov 2;14(1):26378. doi: 10.1038/s41598-024-77497-1.
4
Irisin Ameliorates Muscle Atrophy by Inhibiting the Upregulation of the Ubiquitin‒Proteasome System in Chronic Kidney Disease.鸢尾素通过抑制慢性肾脏病中泛素-蛋白酶体系统的上调来改善肌肉萎缩。
Calcif Tissue Int. 2024 Nov;115(5):712-724. doi: 10.1007/s00223-024-01283-4. Epub 2024 Sep 16.
5
Trajectory of Irisin as a Predictor of Kidney-Related Outcomes in Patients with Asymptomatic Heart Failure.鸢尾素轨迹作为无症状心力衰竭患者肾脏相关结局预测指标的研究
Biomedicines. 2024 Aug 12;12(8):1827. doi: 10.3390/biomedicines12081827.
6
Adipokines and Myokines as Markers of Malnutrition and Sarcopenia in Patients Receiving Kidney Replacement Therapy: An Observational, Cross-Sectional Study.脂肪细胞因子和肌细胞因子作为接受肾脏替代治疗患者营养不良和肌少症的标志物:一项观察性、横断面研究。
Nutrients. 2024 Jul 31;16(15):2480. doi: 10.3390/nu16152480.